Cargando…
Dexamethasone intravitreal implant for macular edema and some other rare indications in uveitis
In the present study, 110 eyes of 81 patients with uveitis who underwent intravitreal dexamethasone implant (IDI) injection and had a follow-up of at least 6 months between January, 2012 and September, 2022, were retrospectively analyzed. A total of 298 IDI injections were administered (mean, 2.71±2...
Autores principales: | Koksaldi, Seher, Kayabaşi, Mustafa, Ayhan, Zıya, Kaya, Mahmut, öztürk, Taylan, Yaman, Aylın, Saatci, Ali Osman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407465/ https://www.ncbi.nlm.nih.gov/pubmed/37560325 http://dx.doi.org/10.3892/mi.2023.99 |
Ejemplares similares
-
Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol
por: Kaya, Mahmut, et al.
Publicado: (2020) -
Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
por: Saatci, Ali Osman, et al.
Publicado: (2013) -
Intraretinal Macroaneurysms and Multimodal Imaging: A Retrospective Analysis
por: Kayabaşı, Mustafa, et al.
Publicado: (2023) -
Intravitreal Dexamethasone Implant in the Treatment of Non-Infectious Uveitic Macular Edema
por: Karti, Omer, et al.
Publicado: (2018) -
Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema
por: Karti, Omer, et al.
Publicado: (2021)